Cargando…
Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain
Plasmid-encoded colistin resistance is emerging among extraintestinal pathogenic Escherichia coli strains, including those of the epidemic clone sequence type 131 (ST131)-H30. Mcr-1 transfers a phosphoethanolamine to the lipid A portion of lipopolysaccharide (LPS), conferring resistance to polymyxin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021686/ https://www.ncbi.nlm.nih.gov/pubmed/29686149 http://dx.doi.org/10.1128/AAC.00046-18 |
_version_ | 1783335515409350656 |
---|---|
author | Guachalla, Luis M. Ramoni, Katharina Varga, Cecilia Mutti, Michele Ghazawi, Akela Pál, Tibor Nagy, Eszter Sonnevend, Ágnes Nagy, Gábor Szijártó, Valéria |
author_facet | Guachalla, Luis M. Ramoni, Katharina Varga, Cecilia Mutti, Michele Ghazawi, Akela Pál, Tibor Nagy, Eszter Sonnevend, Ágnes Nagy, Gábor Szijártó, Valéria |
author_sort | Guachalla, Luis M. |
collection | PubMed |
description | Plasmid-encoded colistin resistance is emerging among extraintestinal pathogenic Escherichia coli strains, including those of the epidemic clone sequence type 131 (ST131)-H30. Mcr-1 transfers a phosphoethanolamine to the lipid A portion of lipopolysaccharide (LPS), conferring resistance to polymyxins. We investigated whether this modification changed the activity of the monoclonal antibody ASN-4, specific to the O25b side chain of ST131 LPS. We confirmed that, unlike colistin, ASN-4 retained its bactericidal and endotoxin-neutralizing activities and therefore offers a treatment option against extremely drug-resistant ST131 isolates. |
format | Online Article Text |
id | pubmed-6021686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-60216862018-07-06 Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain Guachalla, Luis M. Ramoni, Katharina Varga, Cecilia Mutti, Michele Ghazawi, Akela Pál, Tibor Nagy, Eszter Sonnevend, Ágnes Nagy, Gábor Szijártó, Valéria Antimicrob Agents Chemother Experimental Therapeutics Plasmid-encoded colistin resistance is emerging among extraintestinal pathogenic Escherichia coli strains, including those of the epidemic clone sequence type 131 (ST131)-H30. Mcr-1 transfers a phosphoethanolamine to the lipid A portion of lipopolysaccharide (LPS), conferring resistance to polymyxins. We investigated whether this modification changed the activity of the monoclonal antibody ASN-4, specific to the O25b side chain of ST131 LPS. We confirmed that, unlike colistin, ASN-4 retained its bactericidal and endotoxin-neutralizing activities and therefore offers a treatment option against extremely drug-resistant ST131 isolates. American Society for Microbiology 2018-06-26 /pmc/articles/PMC6021686/ /pubmed/29686149 http://dx.doi.org/10.1128/AAC.00046-18 Text en Copyright © 2018 Guachalla et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Experimental Therapeutics Guachalla, Luis M. Ramoni, Katharina Varga, Cecilia Mutti, Michele Ghazawi, Akela Pál, Tibor Nagy, Eszter Sonnevend, Ágnes Nagy, Gábor Szijártó, Valéria Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title | Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title_full | Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title_fullStr | Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title_full_unstemmed | Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title_short | Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain |
title_sort | retained activity of an o25b-specific monoclonal antibody against an mcr-1-producing escherichia coli sequence type 131 strain |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021686/ https://www.ncbi.nlm.nih.gov/pubmed/29686149 http://dx.doi.org/10.1128/AAC.00046-18 |
work_keys_str_mv | AT guachallaluism retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT ramonikatharina retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT vargacecilia retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT muttimichele retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT ghazawiakela retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT paltibor retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT nagyeszter retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT sonnevendagnes retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT nagygabor retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain AT szijartovaleria retainedactivityofano25bspecificmonoclonalantibodyagainstanmcr1producingescherichiacolisequencetype131strain |